THRX

Theravance, Inc. News Headlines

$27.02
*  
0.53
 negative 
1.92%
Get THRX Alerts
*Delayed - data as of Apr. 23, 2014 11:36 ET 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    THRX Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

GSK,Theravance Announce Phase III Study Of FF/VI In COPD
4/22/2014 9:04:00 AM - RTT News

Has Theravance Just Given Away 40% Of Its Value?
4/22/2014 8:43:00 AM - Seeking Alpha

Sector Update: Health Care
4/21/2014 8:22:04 AM - MT Newswires

Sector Update: Health-Care Shares Flat Pre-Market; Sarepta Soars 75% on New Drug Application Plans for Eteplirsen
4/21/2014 8:18:57 AM - MT Newswires

Why You Should Still Be Considering A Bio-Tech Stock, But With A Sensible Hedge
4/14/2014 10:13:00 AM - Martin Tillier

Theravance To Present At Needham Healthcare Conference; Webcast At 9:20 AM ET
4/9/2014 8:20:00 AM - RTT News

First Week of THRX April 19th Options Trading
4/7/2014 11:25:08 AM - BNK Invest

Theravance Is A Classic Ben Graham Bargain
4/4/2014 8:25:00 AM - Seeking Alpha

Theravance: Baby Thrown Out With The Bath Water - 35% To 65% Upside
3/31/2014 2:48:00 PM - Seeking Alpha

First Week of May 17th Options Trading For Theravance (THRX)
3/27/2014 1:01:41 PM - BNK Invest

Theravance Larger Than S&P 500 Component International Game Technology
3/26/2014 4:44:06 PM - BNK Invest

Glaxo/Theravance Update on COPD Drugs - Analyst Blog
3/18/2014 6:30:01 PM - Zacks.com

Update on Glaxo's Pipeline - Analyst Blog
3/17/2014 1:53:01 PM - Zacks.com

GlaxoSmithKline Studies on Lung Disease Drug Show Positive Results -- Update
3/14/2014 9:46:00 AM - Dow Jones Business News

Correction to GSK Drug Studies Story
3/14/2014 9:45:00 AM - Dow Jones Business News

GSK Studies on Lung Disease Drug Show Positive Results
3/14/2014 8:46:00 AM - Dow Jones Business News

Glaxo, Theravance Reveal Positive Results From 3 Late-stage Studies In COPD
3/14/2014 8:14:00 AM - RTT News

Theravance to Split in Q2 - Analyst Blog
3/4/2014 1:00:01 PM - Zacks.com

THRX Crosses Below Key Moving Average Level
2/28/2014 5:43:00 PM - BNK Invest

Update on Teva's DuoResp Spiromax - Analyst Blog
2/25/2014 7:00:01 PM - Zacks.com

CHMP Positive on Glaxo's Two Drugs - Analyst Blog
2/21/2014 5:45:01 PM - Zacks.com

Glaxo's COPD Drug Gets European Green Light
2/20/2014 9:41:00 AM - Fox Business

Tracking Seth Klarman's Baupost Group Holdings - Q4 2013 Update
2/14/2014 3:01:00 AM - Seeking Alpha

Loss at Theravance Wider Than Expected - Analyst Blog
2/7/2014 1:10:01 PM - Zacks.com

Theravance Q4 Loss Widens - Quick Facts
2/6/2014 5:02:00 PM - RTT News